Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects.
Saved in:
| Title: | Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects. |
|---|---|
| Authors: | Chang, Yi‐Chung1 (AUTHOR), Chen, Yi‐Fen1 (AUTHOR), Yang, Chi‐Fan2 (AUTHOR), Ho, Hui‐Ju1 (AUTHOR), Yang, Jen Fu1 (AUTHOR), Chou, Yuan‐Lin2 (AUTHOR), Lin, Ching‐Wen1 (AUTHOR), Yang, Pan‐Chyr3,4,5 (AUTHOR) pcyang@ntu.edu.tw |
| Source: | CTS: Clinical & Translational Science. Mar2025, Vol. 18 Issue 3, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
